Position in ARGX
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$884,164
+$188,236 QoQ
Shares Held
953
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#260
of 504 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Central Pacific Bank - Trust Division holds $6,691,792 across 10 Biotechnology names. ARGX ranks #2 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,123 | $2,544,747 | |
| 2 | ARGX |
Argenx SE
This page
|
953 | $884,164 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,412 | $880,438 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,145 | $614,807 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
7,767 | $578,486 | |
| 6 | INCY |
Incyte Corp
|
3,325 | $376,922 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
5,350 | $306,127 | |
| 8 | TECH |
BIO-TECHNE Corp
|
3,180 | $224,667 |
All Filings in ARGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $884,164 | 953 | Shares | Defined | 2026-07-07 | |
| 2026-03-31 | $695,928 | 953 | Shares | Defined | 2026-04-08 | |
| 2025-12-31 | $801,425 | 953 | Shares | Defined | 2026-01-07 | |
| 2025-09-30 | $932,275 | 1,264 | Shares | Defined | 2025-10-02 | |
| 2025-06-30 | $704,459 | 1,278 | Shares | Defined | 2025-07-02 | |
| 2025-03-31 | $738,647 | 1,248 | Shares | Defined | 2025-04-03 | |
| 2024-12-31 | $615,000 | 1,000 | Shares | Defined | 2025-01-03 | |
| 2024-03-31 | $310,645 | 789 | Shares | Defined | 2024-05-02 | |
| No filing history on record for this holder in this stock. | ||||||